Clinical Trials · NCT00595140
Acute Application of Pegvisomant and Octreotide in Acromegaly
- Phase
- Phase 4
- Recruitment status
- Completed
- Sponsor
- Ludwig-Maximilians - University of Munich
- Enrollment
- 10
- Start date
- Jan 2008
- Locations
- 1 site, Germany
- Primary endpoint
- The decrease of endogenous growth hormone